While ZO-1 is typically downregulated in active UC and DSS-induced murine models [81,82] some studies have reported elevated ZO-1 expression in quiescent UC patients and in certain cancers, including colorectal and bladder cancer [83,84]. This evidence concerns the gene TJP1 and urinary bladder cancer.